AU7653600A - Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis - Google Patents

Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis

Info

Publication number
AU7653600A
AU7653600A AU76536/00A AU7653600A AU7653600A AU 7653600 A AU7653600 A AU 7653600A AU 76536/00 A AU76536/00 A AU 76536/00A AU 7653600 A AU7653600 A AU 7653600A AU 7653600 A AU7653600 A AU 7653600A
Authority
AU
Australia
Prior art keywords
biarylbutyric
substituted
treatment
multiple sclerosis
acid derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU76536/00A
Inventor
Gabriele Braunlich
Thomas Fahrig
Helmut Haning
Rolf Henning
Bernd dr. Riedl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU7653600A publication Critical patent/AU7653600A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
AU76536/00A 1999-09-24 2000-09-12 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis Abandoned AU7653600A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9922710.0A GB9922710D0 (en) 1999-09-24 1999-09-24 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatatives for the treatment of multiple sclerosis
GB9922710 1999-09-24
PCT/EP2000/008890 WO2001022951A2 (en) 1999-09-24 2000-09-12 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis

Publications (1)

Publication Number Publication Date
AU7653600A true AU7653600A (en) 2001-04-30

Family

ID=10861599

Family Applications (1)

Application Number Title Priority Date Filing Date
AU76536/00A Abandoned AU7653600A (en) 1999-09-24 2000-09-12 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis

Country Status (6)

Country Link
EP (1) EP1217994A2 (en)
JP (1) JP2003510272A (en)
AU (1) AU7653600A (en)
CA (1) CA2385490A1 (en)
GB (1) GB9922710D0 (en)
WO (1) WO2001022951A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2832633B1 (en) * 2001-11-28 2004-09-24 Lipha PHARMACEUTICAL COMPOSITION COMPRISING A METFORMIN ASSOCIATION AND A 4-OXO-BUTANOIC ACID AND ITS USE FOR TREATING DIABETES
FR2832927A1 (en) * 2001-12-03 2003-06-06 Lipha PHARMACEUTICAL COMPOSITION COMPRISING A 4-OXO-BUTANOIC ACID AND A THIAZOLIDINEDIONE DERIVATIVE AND USE THEREOF FOR THE PREPARATION OF MEDICAMENTS FOR THE TREATMENT OF DIABETES
FR2834214B1 (en) * 2001-12-28 2004-09-24 Lipha PHARMACEUTICAL COMPOSITION COMPRISING AN ALPHA-GLUCOSIDASE INHIBITOR AND 4-OXO-BUTANOIC ACID AND ITS USE FOR TREATING DIABETES
FR2834640B1 (en) * 2002-01-11 2004-09-24 Lipha PHARMACEUTICAL COMPOSITION COMPRISING A GLITAZONE AND A 4-OXOBUTANOIC ACID AND ITS USE FOR TREATING DIABETES
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
CN103086947A (en) * 2011-11-04 2013-05-08 赵庆春 Phthalimide compounds with antiangiogenic activity and purpose thereof
CN113185447B (en) * 2021-05-06 2023-07-21 四川大学 Phthaloyl cysteamine compound, preparation method and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5789434A (en) * 1994-11-15 1998-08-04 Bayer Corporation Derivatives of substituted 4-biarylbutyric acid as matrix metalloprotease inhibitors
HRP970244B1 (en) * 1996-05-15 2005-06-30 Bayer Corporation Inhibition of matrix metalloproteases by 2-substit
US6288063B1 (en) * 1998-05-27 2001-09-11 Bayer Corporation Substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors

Also Published As

Publication number Publication date
EP1217994A2 (en) 2002-07-03
WO2001022951A3 (en) 2001-10-11
CA2385490A1 (en) 2001-04-05
GB9922710D0 (en) 1999-11-24
JP2003510272A (en) 2003-03-18
WO2001022951A2 (en) 2001-04-05

Similar Documents

Publication Publication Date Title
AU4205100A (en) Methods and compositions for the treatment of pancreatitis
AU4520801A (en) Novel substituted phenanthridinones and methods of use thereof
AU2495200A (en) Compositions and methods for the treatment of tumor
AU2003200722A1 (en) Compositions and methods for the treatment of tumor
AU2003200740A1 (en) Compositions and methods for the treatment of tumor
AU2003200731A1 (en) Compositions and methods for the treatment of tumor
AU2072201A (en) Agents and methods for the treatment of proliferative diseases
AU782631C (en) Novel heterocyclic compounds and salts thereof and medicinal use of the same
AU2575201A (en) Use of hsp27 as an anti-inflammatory agent
AU4364400A (en) Azaindole derivatives for the treatment of depression
AU2002220735A1 (en) Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain
AU5116100A (en) Connector and method of use of the connector
AU7958100A (en) Crystals of an oxyiminoalkanoic acid derivative and their use as antidiabetics
AU5056099A (en) Compounds for use in the treatment of inflammation
AU4998100A (en) Methods of using percarboxylic acid or anions thereof and methods of making the same
AU5428700A (en) Acrylic acid derivatives, use of the same and intermediates for the preparation thereof
AU2021601A (en) Composition for the treatment of dandruff
AU1878201A (en) Composition for the treatment of damaged tissue
AU7653600A (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis
AU1053501A (en) Polyazanaphthalene compound and medicinal use thereof
AU3760900A (en) Treatment of menstrual function
AU2566201A (en) Compounds and methods for the treatment of pain
AU2420101A (en) Method and composition for the treatment of pain
AU1405001A (en) Treatment of diseases
AU1022501A (en) Use of compositions for the caring treatment of the skin

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase